吉西他滨
埃罗替尼
医学
内科学
胰腺癌
盐酸厄洛替尼
肿瘤科
危险系数
不利影响
安慰剂
临床终点
临床试验
癌症
表皮生长因子受体
置信区间
病理
替代医学
作者
Malcolm J. Moore,David Goldstein,John Hamm,Arié Figer,J. Randolph Hecht,Steven Gallinger,H. Au,P. Murawa,David Walde,Robert A. Wolff,Daniel de Castro,Robert Lim,Keyue Ding,Gary M. Clark,Theodora Voskoglou-Nomikos,Mieke Ptasynski,Wendy R. Parulekar
标识
DOI：10.1200/jco.2006.07.9525
摘要
To our knowledge, this randomized phase III trial is the first to demonstrate statistically significantly improved survival in advanced pancreatic cancer by adding any agent to gemcitabine. The recommended dose of erlotinib with gemcitabine for this indication is 100 mg/d.
科研通智能强力驱动
Strongly Powered by AbleSci AI
PDF的下载单位、IP信息已删除
(2025-6-4)
嘻嘻哈哈
Criminology34
Kao
无极微光
GingerF
ricardo
OK
Copyright
youtianyi
潇洒柏柳
cnspower
cdercder
lizishu
爆爆
贪玩的秋柔
烟消云散
Kelley
强健的面包
核桃
richard
皖公网安备34019202002308
